Cargando…
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306650/ https://www.ncbi.nlm.nih.gov/pubmed/32571394 http://dx.doi.org/10.1186/s13063-020-04519-4 |
| _version_ | 1783548698182025216 |
|---|---|
| author | Maes, Bastiaan Bosteels, Cedric De Leeuw, Elisabeth Declercq, Jozefien Van Damme, Karel Delporte, Anja Demeyere, Bénédicte Vermeersch, Stéfanie Vuylsteke, Marnik Willaert, Joren Bollé, Laura Vanbiervliet, Yuri Decuypere, Jana Libeer, Frederick Vandecasteele, Stefaan Peene, Isabelle Lambrecht, Bart N. |
| author_facet | Maes, Bastiaan Bosteels, Cedric De Leeuw, Elisabeth Declercq, Jozefien Van Damme, Karel Delporte, Anja Demeyere, Bénédicte Vermeersch, Stéfanie Vuylsteke, Marnik Willaert, Joren Bollé, Laura Vanbiervliet, Yuri Decuypere, Jana Libeer, Frederick Vandecasteele, Stefaan Peene, Isabelle Lambrecht, Bart N. |
| author_sort | Maes, Bastiaan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7306650 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73066502020-06-22 Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial Maes, Bastiaan Bosteels, Cedric De Leeuw, Elisabeth Declercq, Jozefien Van Damme, Karel Delporte, Anja Demeyere, Bénédicte Vermeersch, Stéfanie Vuylsteke, Marnik Willaert, Joren Bollé, Laura Vanbiervliet, Yuri Decuypere, Jana Libeer, Frederick Vandecasteele, Stefaan Peene, Isabelle Lambrecht, Bart N. Trials Correction BioMed Central 2020-06-22 /pmc/articles/PMC7306650/ /pubmed/32571394 http://dx.doi.org/10.1186/s13063-020-04519-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Maes, Bastiaan Bosteels, Cedric De Leeuw, Elisabeth Declercq, Jozefien Van Damme, Karel Delporte, Anja Demeyere, Bénédicte Vermeersch, Stéfanie Vuylsteke, Marnik Willaert, Joren Bollé, Laura Vanbiervliet, Yuri Decuypere, Jana Libeer, Frederick Vandecasteele, Stefaan Peene, Isabelle Lambrecht, Bart N. Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial |
| title | Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial |
| title_full | Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial |
| title_fullStr | Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial |
| title_full_unstemmed | Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial |
| title_short | Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial |
| title_sort | correction to: treatment of severely ill covid-19 patients with anti-interleukin drugs (cov-aid): a structured summary of a study protocol for a randomised controlled trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306650/ https://www.ncbi.nlm.nih.gov/pubmed/32571394 http://dx.doi.org/10.1186/s13063-020-04519-4 |
| work_keys_str_mv | AT maesbastiaan correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT bosteelscedric correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT deleeuwelisabeth correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT declercqjozefien correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT vandammekarel correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT delporteanja correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT demeyerebenedicte correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT vermeerschstefanie correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT vuylstekemarnik correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT willaertjoren correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT bollelaura correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT vanbiervlietyuri correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT decuyperejana correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT libeerfrederick correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT vandecasteelestefaan correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT peeneisabelle correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial AT lambrechtbartn correctiontotreatmentofseverelyillcovid19patientswithantiinterleukindrugscovaidastructuredsummaryofastudyprotocolforarandomisedcontrolledtrial |